Ignite Creation Date:
2024-05-05 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00231231
Status:
COMPLETED
Last Update Posted:
2007-07-20
First Post:
2005-09-30
Brief Title:
Carotid Artery Stenting With Emboli Protection Surveillance-Post-Marketing Study CASES-PMS
Sponsor:
Cordis Corporation
Organization:
Cordis Corporation
Study Overview
Official Title:
Carotid Artery Stenting With Emboli Protection Surveillance-Post-Marketing Study CASES-PMS
Status:
COMPLETED
Status Verified Date:
2007-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary objective of this study is to assess the outcomes of stenting with distal protection in the treatment of obstructive carotid artery disease during peri-approvalinitial commercialization in relation to the outcomes of the Sapphire Clinical Trial The devices to be utilized are the Cordis PRECISE Nitinol Stent Systems and the Cordis ANGIOGUARD XP Emboli Capture Guidewire ECGW
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None